Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Publication of GT200400230ApublicationCriticalpatent/GT200400230A/en
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE LA FORMULA GENERAL I EN LA QUE R1,W1,W2,Y,N,Z,X,L,SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS SON ANTAGONISTAS DE LAS PROTEINAS DE ADHESION DE MAMIFERO CONOCIDAS COMO SELECTINAS POR LO QUE SON DE UTILIDAD COMO SUSTANCIAS ANTIINFLAMATORIAS.THIS INVENTION CONCERNS COMPOUNDS OF GENERAL FORMULA I IN WHICH R1, W1, W2, Y, N, Z, X, L, ARE FUNCTIONAL GROUPS DESCRIBED IN THE RECORD. THESE COMPOUNDS ARE ANTAGONISTS OF THE PROTEINS OF MAMMER ADHESION KNOWN AS SELECTINES, SO THEY ARE USEFUL AS ANTI-INFLAMMATORY SUBSTANCES.
GT200400230A2003-11-102004-11-09
METHODS AND COMPOSITIONS FOR SELECTIN INHIBITION
GT200400230A
(en)
PIRROLO DERIVATIVES [3,4-C] PIRAZOL, ASSETS AS QUINASE INHIBITORS, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM. (FRACTIONARY APPLICATION NO. 1, DERIVED FROM THE PATENT NO. PI-2004-0133).
PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVE AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNOLOGICALLY MEDIATED DISEASES